4.25 (-%)
As of Dec 03, 2024
Source:
DBV Technologies is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin.
Country | France |
Headquarters | montrouge, france |
Phone Number | 33 1 55 42 78 78 |
Industry | manufacturing |
CEO | Daniel Tass |
Website | www.dbv-technologies.com |